15,633 results on '"HELICOBACTER pylori infections"'
Search Results
2. The Helicobacter pylori infection alters the intercellular junctions on the pancreas of gerbils (Meriones unguiculatus).
- Author
-
Hurtado-Monzón, Edgar G., Valencia-Mayoral, Pedro, Silva-Olivares, Angélica, Bañuelos, Cecilia, Velázquez-Guadarrama, Norma, and Betanzos, Abigail
- Subjects
- *
MONGOLIAN gerbil , *CELL junctions , *HELICOBACTER pylori infections , *ADHERENS junctions , *HELICOBACTER pylori , *PANCREAS , *OCCLUDINS - Abstract
Helicobacter pylori is a common resident in the stomach of at least half of the world's population and recent evidence suggest its emergence in other organs such as the pancreas. In this organ, the presence of H. pylori DNA has been reported in cats, although the functional implications remain unknown. In this work, we determined distinct features related to the H. pylori manifestation in pancreas in a rodent model, in order to analyse its functional and structural effect. Gerbils inoculated with H. pylori exhibited the presence of this bacterium, as revealed by the expression of some virulence factors, as CagA and OMPs in stomach and pancreas, and confirmed by urease activity, bacterial culture, PCR and immunofluorescence assays. Non-apparent morphological changes were observed in pancreatic tissue of infected animals; however, delocalization of intercellular junction proteins (claudin-1, claudin-4, occludin, ZO-1, E-cadherin, β-catenin, desmoglein-2 and desmoplakin I/II) and rearrangement of the actin-cytoskeleton were exhibited. This structural damage was consistent with alterations in the distribution of insulin and glucagon, and a systemic inflammation, event demonstrated by elevated IL-8 levels. Overall, these findings indicate that H. pylori can reach the pancreas, possibly affecting its function and contributing to the development of pancreatic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Review of foodborne helicobacteriosis.
- Author
-
Almashhadany, Dhary Alewy, Zainel, Mustafa Abdulmonam, and AbdulRahman, Taha Talal
- Subjects
- *
RESTRICTION fragment length polymorphisms , *HELICOBACTER pylori infections , *HELICOBACTER pylori , *FOOD contamination , *BACTERIAL diseases - Abstract
Helicobacteriosis is a common bacterial infection caused by Helicobacter pylori. It affects the stomach and small intestines, leading to inflammation. Bacteria can spread through contaminated food or water. This review explores the role of food in the transmission of H. pylori, drawing on research from the past three decades. People commonly acquire the infection during childhood, often from close family members. Crowded living conditions can also contribute to the spread. This review also discusses various risk factors and highlights the challenges of detecting H. pylori, particularly in its dormant form. Techniques like ribotyping and restriction fragment length polymorphism hold promise for tracing transmission routes, but more long-term studies are needed to account for potential confounding factors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Diagnostic yield of bidirectional endoscopy for iron deficiency anemia in young patients.
- Author
-
Abramowitz, Binyamin R., Saba, Helena, Aytaman, Ayse, DiLeo, Daniel A., and Roland, Bani Chander
- Subjects
- *
IRON deficiency anemia , *ASYMPTOMATIC patients , *ANTIHISTAMINES , *PROTON pump inhibitors , *VETERANS' hospitals , *HELICOBACTER pylori infections - Abstract
Background: While bidirectional endoscopy is recognized as the standard approach for investigating iron deficiency anemia (IDA) in men older than 45 and postmenopausal women, evidence supporting the application of this approach in younger men and premenopausal women is scarce in the absence of symptoms. Our primary aim is to identify the diagnostic yield of bidirectional endoscopy in men younger than 45 and premenopausal women, and describe the clinical characteristics of those with significant endoscopic and pathology-proven findings. Methods: We performed a retrospective chart review including patients younger than age 45 with IDA who underwent esophagogastroduodenoscopy (EGD) and/or colonoscopy at the Brooklyn VA Hospital between 2009 and 2023. Demographic, clinical, and endoscopic patient data was all collected, stratified, analyzed, and interpreted. Results: In 143 patients younger than age 45 with IDA, 28.6% were found to have positive upper gastrointestinal (GI) findings, of which 70.3% were pathology-proven H. pylori cases. 57.9% of patients reported upper GI symptoms, while 42.9% of patients were asymptomatic. In total, 18.2% of symptomatic patients were found to have clinically significant findings on EGD as compared with 42.9% of asymptomatic patients. Additionally, 9.1% of symptomatic patients were found to have biopsy proven H. pylori-associated gastritis or duodenitis as compared with 33.9% of asymptomatic patients. Of the patients who underwent colonoscopy, 8.3% were found to have lower GI lesions. Conclusions: We found the diagnostic yield of EGD to be significantly higher than that of colonoscopy in younger IDA patients. Our findings suggest current guidelines are clinically relevant to the young patient cohort. Our study also found asymptomatic IDA patients below age 45 to have a significantly higher diagnostic yield of EGD as compared to symptomatic IDA patients within the same age cohort. The differences in diagnostic yields may be a result of symptomatic patients being more likely to have been prescribed proton pump inhibitors or histamine receptor antagonists prior to endoscopy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Contents list.
- Subjects
- *
CAREER development , *HELICOBACTER pylori infections , *ANALYSIS of heavy metals , *SILICA films , *METAL nanoparticles , *PLASTIC marine debris , *FLUOROPOLYMERS , *SERS spectroscopy - Abstract
The document is a contents list for the journal "Analyst" published by the Royal Society of Chemistry. It includes a range of articles and papers on various topics related to chemistry and chemical sciences. Some of the topics covered include fluorescent carbon dots, metal nanoparticles, biosensing systems, nanoplastic detection, and electrochemical analysis. The journal aims to connect the global chemistry community and reinvest its profits back into the field. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
6. High-precision Helicobacter pylori infection diagnosis using a dual-element multimodal gas sensor array.
- Author
-
Wu, Jiaying, Xu, Shiyuan, Liu, Xuemei, Zhao, Jingwen, He, Zhengfu, Pan, Aiwu, and Wu, Jianmin
- Subjects
- *
HELICOBACTER pylori infections , *SENSOR arrays , *GAS detectors , *HELICOBACTER pylori , *DIAGNOSIS methods - Abstract
Helicobacter pylori (H. pylori) is a globally widespread bacterial infection. Early diagnosis of this infection is vital for public and individual health. Prevalent diagnosis methods like the isotope 13C or 14C labelled urea breath test (UBT) are not convenient and may do harm to the human body. The use of cross-response gas sensor arrays (GSAs) is an alternative way for label-free detection of metabolite changes in exhaled breath (EB). However, conventional GSAs are complex to prepare, lack reliability, and fail to discriminate subtle changes in EB due to the use of numerous sensing elements and single dimensional signal. This work presents a dual-element multimodal GSA empowered with multimodal sensing signals including conductance (G), capacitance (C), and dissipation factor (DF) to improve the ability for gas recognition and H. pylori-infection diagnosis. Sensitized by poly(diallyldimethylammonium chloride) (PDDA) and the metal–organic framework material NH2-UiO66, the dual-element graphene oxide (GO)-composite GSAs exhibited a high specific surface area and abundant adsorption sites, resulting in high sensitivity, repeatability, and fast response/recovery speed in all three signals. The multimodal sensing signals with rich sensing features allowed the GSA to detect various physicochemical properties of gas analytes, such as charge transfer and polarization ability, enhancing the sensing capabilities for gas discrimination. The dual-element GSA could differentiate different typical standard gases and non-dehumidified EB samples, demonstrating the advantages in EB analysis. In a case–control clinical study on 52 clinical EB samples, the diagnosis model based on the multimodal GSA achieved an accuracy of 94.1%, a sensitivity of 100%, and a specificity of 90.9% for diagnosing H. pylori infection, offering a promising strategy for developing an accurate, non-invasive and label-free method for disease diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Causal associations between Helicobacter Pylori infection and the risk and symptoms of Parkinson's disease: a Mendelian randomization study.
- Author
-
Xin Wang, Deming Jiang, Xiao Zhang, Ran Wang, Fengyi Yang, and Chunrong Xie
- Subjects
PARKINSON'S disease ,GENOME-wide association studies ,MEMBRANE proteins ,SYMPTOMS ,HELICOBACTER pylori ,HELICOBACTER pylori infections - Abstract
Background: Increasing evidence suggests an association between Helicobacter pylori (HP) infection and Parkinson's disease (PD) and its clinical manifestations, but the causal relationship remain largely unknown. Objective: To investigate the causal relationship between HP infection and PD risk, PD symptoms, and secondary parkinsonism, we conducted two-sample Mendelian randomization (MR). Methods: We obtained summary data from genome-wide association studies for seven different antibodies specific to HP proteins and five PD-related phenotypes. The inverse-variance weighted (IVW), weighted median, weighted mode, and MR-Egger methods were used to assess the causal relationships. Sensitivity analyses were performed to examine the stability of the MR results and reverse MR analysis was conducted to evaluate the presence of reverse causality. Results: Genetically predicted HP antibodies were not causally associated with an increased risk of PD. However, HP cytotoxin-associated gene-A (CagA) and outer membrane protein (OMP) antibody level were causally associated with PD motor subtype (tremor to postural instability/gait difficulty score ratio; β = -0.16 and 0.46, P = 0.002 and 0.048, respectively). HP vacuolating cytotoxin-A (VacA) antibody level was causally associated with an increased risk of PD dementia [odds ratio (OR) = 1.93, P = 0.040]. Additionally, HP OMP antibody level was identified as a risk factor for drug-induced secondary parkinsonism (OR = 2.08, P = 0.033). These results were stable, showed no evidence of heterogeneity or directional pleiotropy, and no evidence of a reverse causal relationship. Conclusions: Our findings indicate that HP infection does not increase the risk of PD, but contributes to PD motor and cognitive symptoms. Different types of HP antibodies affect different symptoms of PD. Eradication of HP infection may help modulate and improve symptoms in PD patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Targeted nanotherapeutics for the treatment of Helicobacter pylori infection.
- Author
-
Chitas, Rute, Fonseca, Diana R., Parreira, Paula, and Martins, M. Cristina L.
- Subjects
- *
HELICOBACTER pylori infections , *HELICOBACTER pylori , *GASTRIC mucosa , *BACTERIAL cell walls , *GASTRIC diseases - Abstract
Helicobacter pylori infection is involved in gastric diseases such as peptic ulcer and adenocarcinoma. Approved antibiotherapies still fail in 10 to 40% of the infected patients and, in this scenario, targeted nanotherapeutics emerged as powerful allies for H. pylori eradication. Nano/microparticles conjugated with H. pylori binding molecules were developed to eliminate H. pylori by either (i) blocking essential mechanisms of infection, such as adhesion to gastric mucosa or (ii) binding and killing H. pylori through the release of drugs within the bacteria or at the site of infection. Glycan antigens (as Lewis B and sialyl-Lewis X), pectins, lectins, phosphatidylethanolamine and epithelial cell membranes were conjugated with nano/microparticles to successfully block H. pylori adhesion. Urea-coated nanoparticles were used to improve drug delivery inside bacteria through H. pylori UreI channel. Moreover, nanoparticles coated with antibodies against H. pylori and loaded with sono/photosensitizers, were promising for their application as targeted sono/photodynamic therapies. Further, non-specific H. pylori nano/microparticles, but only active in the acidic gastric environment, coated with binders to bacterial membrane, extracellular polymeric substances or to high temperature requirement A protease, were evaluated. In this review, an overview of the existing nanotherapeutics targeting H. pylori will be given and their rational, potential to counteract infection, as well as level of development will be presented and discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Programmed cell death in Helicobacter pylori infection and related gastric cancer.
- Author
-
Yukun Lin, Kunjing Liu, Fang Lu, Changming Zhai, and Fafeng Cheng
- Subjects
HELICOBACTER pylori infections ,APOPTOSIS ,HELICOBACTER pylori ,GASTRIC mucosa ,STOMACH cancer ,ALIMENTARY canal - Abstract
Programmed cell death (PCD) plays a crucial role in maintaining the normal structure and function of the digestive tract in the body. Infection with Helicobacter pylori (H. pylori) is an important factor leading to gastric damage, promoting the Correa cascade and accelerating the transition from gastritis to gastric cancer. Recent research has shown that several PCD signaling pathways are abnormally activated during H. pylori infection, and the dysfunction of PCD is thought to contribute to the development of gastric cancer and interfere with treatment. With the deepening of studies on H. pylori infection in terms of PCD, exploring the interaction mechanisms between H. pylori and the body in different PCD pathways may become an important research direction for the future treatment of H. pylori infection and H. pylori-related gastric cancer. In addition, biologically active compounds that can inhibit or induce PCD may serve as key elements for the treatment of this disease. In this review, we briefly describe the process of PCD, discuss the interaction between different PCD signaling pathways and the mechanisms of H. pylori infection or H. pylori-related gastric cancer, and summarize the active molecules that may play a therapeutic role in each PCD pathway during this process, with the expectation of providing a more comprehensive understanding of the role of PCD in H. pylori infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Study of the association between the chemokine CXCL5 and the onset of chronic atrophic gastritis and gastric precancerous lesions.
- Author
-
PEI Bei, ZHANG Yi, SUN Qin, JIN Yueping, and LI Xuejun
- Subjects
- *
CHEMOKINES , *ATROPHIC gastritis , *PRECANCEROUS conditions , *HELICOBACTER pylori infections , *LOGISTIC regression analysis , *GENE expression - Abstract
Objective To clarify the changes in CXCL5 in serum and gastric tissues of patients with chronic atrophic gastritis (CAG) and precancerous lesions of gastric cancer (PLGC) and to investigate the predictive value of CXCL5 for the diagnosis of CAG and PLGC. Methods This study enrolled 72 participants of CAG admitted to the Department of Splenology and Gastroenterology of the Second Affiliated Hospital of Anhui University of Chinese Medicine from June 2022 to June 2023, with gastroscopy and pathologically confirmed diagnosis, as well as 68 healthy participants who underwent gastroscopy in the same period at our department. We collected clinical information and laboratory results from all participants. The logistic regression analysis methods were used to identify the diagnostic value of serum CXCL5. Furthermore, in order to clarify the role of CXCL5 in the development of CAG, a total of 15 patients each with CAG, intestinal metaplasia, and dysplasia treated at our hospital from June 2023 to December 2023, and 15 healthy participants were selected. The relationship between the expression of CXCL5 and the degree of clinicopathology was analysed in each group using ELISA, PCR, and immunohistochemistry staining to validate and assess the diagnostic efficacy of CXCL5. Results The study found that several factors were associated with CAG, including family history of tumours, smoking and alcohol consumption history, dietary regularity, Helicobacter pylori infection, the number of lesions, gastric function scores and CXCL5 (P < 0.05). The ROC curve had an AUC of 1.00 and a Youden index of 0.986, indicating excellent predictive ability. The ELISA results indicated a significantly higher serum CXCL5 expression level in the CAG, intestinal metaplasia, and dysplasia groups compared to the normal group. There was a positive correlation between the serum CXCL5 expression level and the degree of pathology. The PCR and immunohistochemistry staining results indicate that the mRNA and protein expression levels of CXCL5 in gastric tissues of patient groups were significantly higher compared to the normal group. Furthermore, the mRNA and protein expression levels of CXCL5 in gastric tissues were positively correlated with the degree of pathology. Conclusions The results indicate that CXCL5 is highly expressed in the serum and gastric tissues of patients with CAG and PLGC, and its expression level is positively correlated with the degree of pathology. Therefore, CXCL5 could serve as a predictive indicator and a potential therapeutic target for the diagnosis of CAG and PLGC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Evaluation of the Rock1 and microRNA-148a expression in biopsies collected from patients with Helicobacter pylori induced gastritis.
- Author
-
Gholamhosseinzadeh, Ebrahim, Ghalehnoei, Hossein, Kazemi Veisari, Arash, Jafari, Narjes, and Goli, Hamid Reza
- Subjects
- *
GENE expression , *METASTASIS , *HELICOBACTER pylori , *HELICOBACTER pylori infections , *BACTERIAL diseases , *GASTRITIS - Abstract
Background: Helicobacter pylori infection is one of the most common chronic bacterial infections, especially in developing countries. MicroRNA-148a is involved in the regulation of various genes, including Rock1, which is altered in gastric cancer. Decreased expression of mir-148a leads to tumor metastasis and increased Rock1 gene expression in gastric cancer. This study aimed to investigate the expression of these genes in biopsies collected from patients with H. pylori induced gastritis. Methods: Informed consent forms were gotten from the studied patients with gastritis who needed endoscopy. Gastric biopsies were taken by a gastroenterologist from patients with inflammation. Rapid urease test, stool antigen detection, and histopathological staining were used to determine the H. pylori infected patients. Real time PCR was used to evaluate the miRNA and Rock1 expression levels. Results: The Rock1 expression level in biopsies that were positive for H. pylori was significantly increased compared to our control gastritis group that were H. pylori-negative, but the results were not statistically significant. Moreover, the mir-148a expression level in H. pylori-positive patients with gastritis was increased compared to our control group. However, the results were not statistically significant. We did not find a significant relation between the expression levels of Rock1 and mir-148a in samples with gastritis infected or uninfected by H. pylori. This result may be due to the small sample size. Conclusion: We suggest that this test should be carried out with more samples, and the comparison should be done between biopsies with inflammation and no inflammation in a patient. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Causal association between Helicobacter pylori infection and Sjogren's syndrome: a bidirectional Mendelian randomization analysis.
- Author
-
Cui, Dinglu, An, Rongxian, Li, Lei, Jiang, Long, Jiang, Chunshan, and Jin, Jingchun
- Subjects
- *
SJOGREN'S syndrome , *HELICOBACTER pylori infections , *HELICOBACTER pylori , *GENOME-wide association studies , *CAUSAL inference - Abstract
Background: The results of observational studies indicate a potential link between Helicobacter pylori infection and Sjogren's syndrome (SS), but the causal relationship between them remains unknown. This study applied Mendelian randomization (MR) to evaluate this relationship. Method: Genome-wide association study (GWAS) summary statistics on H. pylori infection [sample size=8735 (EBI, https://gwas.mrcieu.ac.uk/)] and SS [sample size=368,028 (cases=2495, controls=365533) (FinnGen, https://r9.finngen.fi/)] were analyzed. We used bidirectional MR to evaluate the association between H. pylori infection and SS and identify causation. The major MR analysis method was inverse-variance weighted (IVW) MR, supplemented by MR‒Egger and weighted median approaches. In addition, the stability and reliability of the results were tested using the retention method, heterogeneity test, and horizontal gene pleiotropy test. Results: Evidence of the impact of H. pylori infection on SS risk was found in the IVW results [odds ratio (OR)=1.6705; 95% confidence interval (CI)=1.0966 to 2.5446; P=0.0168]. Evidence of the impact of SS on H. pylori infection risk was also found (OR=1.0158; 95% CI=1.0033 to 1.0285; P=0.0128). Conclusion: The results of MR analysis support a causal association between H. pylori infection and SS and indicate that SS can lead to a greater risk of H. pylori infection. Our research will support the development of novel approaches for continued H. pylori and SS-related research and therapy that consider the genetic relationship between H. pylori infection and SS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Use of bidirectional Mendelian randomization to unveil the association of Helicobacter pylori infection and autoimmune thyroid diseases.
- Author
-
Kai Wang, Qinnan Zhang, Panpan Zhang, Qian Yang, Fanfan Pan, and Bingbing Zha
- Subjects
- *
HELICOBACTER pylori , *HELICOBACTER pylori infections , *THYROID diseases , *AUTOIMMUNE diseases , *MEMBRANE proteins , *HYPERTHYROIDISM - Abstract
Previous observational studies found associations between Helicobacter pylori infection and autoimmune thyroid diseases (AITDs), but the causal nature of this association is still uncertain. We investigated the causal effect of six crucial antibodies against H. pylori on AITDs using a bidirectional Mendelian randomization (MR). We found that anti-H. pylori outer membrane protein (OMP) significantly increased the risk of hyperthyroidism and Graves' disease (GD). In addition, our reverse MR analysis indicated that hyperthyroidism could increase the levels of cytotoxin-associated gene A and OMP antibodies. We also observed causal roles of GD on anti-H. pylori OMP. Our analyses indicate the mutual effects of H. pylori infection and AITDs, suggesting the existence of a gut-thyroid axis. These results also provide evidence of the bidirectional causal association between anti-H. pylori OMP with hyperthyroidism and GD, resulting in a vicious circle. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Functional determination of site-mutations in rdxA involved in metronidazole resistance of Helicobacter pylori.
- Author
-
Jia Huang, Zhiyu Li, Fulin Ge, Chao Sun, Zixin Deng, Weiyan Yao, and Xinyi He
- Subjects
SINGLE nucleotide polymorphisms ,HELICOBACTER pylori ,ESCHERICHIA coli ,HELICOBACTER pylori infections ,NUCLEIC acids ,PROMOTERS (Genetics) - Abstract
Background: Metronidazole (MTZ) is among the first-line drugs against the human gastric pathogen Helicobacter pylori (H. pylori). MTZ is used as a prodrug that is activated by an oxygen-insensitive enzyme NADPH nitroreductase (RdxA). Loss-of-function mutations in rdxA make H. pylori MTZ resistant; however, experimental proof is lacking. Methods: We collected 139 gastric biopsy samples from patients suspected of H. pylori infection in Shanghai, and amplified Hp-specific rdxA gene from 134 samples. All these rdxA genes were sequenced and phylogenetically compared. The effect of mutations on RdxA function was measured by expressing them in Escherichia coli DH5a by using the MTZ sensitivity test. Results: In total, 134 gastric biopsy samples were identified as H. pylori positive. Of the 134 samples, 74 and 6 had point mutations at the various sites or promoter region of rdxA, generating truncated and extended fused proteins, respectively. The remaining 54 were full-length with single nucleotide variation (SNV) compared with the wild-type RdxA from H. pylori, with 49 clustering with hpEastAsia, 3 with hpEurope, and 2 with hpNEAfrica. All 134 rdxA were expressed in E. coli DH5a; 22 and 112 resultant strains showed MTZ-sensitive and MTZ-resistant phenotypes, respectively. Comparative analysis of single nucleotide polymorphisms (SNPs) in the functional and inactivated RdxA revealed 14 novel mutations in RdxA, 5 of which conferred MTZ resistance: S18F, D59S, L62I, S79N, and A187V. Conclusion: The occurrence of MTZ resistance induced by site-mutation of RdxA in patients with H. pylori infection was 83.6% (112/134) in the Shanghai region. The major form of loss-of-function mutation was truncation of RdxA translation at a rate of 58/112 (51.8%). Molecular detection reliably determined the resistance of H. pylori to MTZ. Thus, the functional mutants involved in MTZ resistance facilitate clinical diagnosis and medication based on sequence analysis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Molecular tools of antibiotic resistance for Helicobacter pylori: an overview in Latin America.
- Author
-
Contreras, Monica, Mujica, Heisser, and García-Amado, María Alexandra
- Subjects
- *
DRUG resistance in bacteria , *HELICOBACTER pylori , *DRUG resistance in microorganisms , *GENETIC mutation , *GENOTYPES , *HELICOBACTER pylori infections - Abstract
Antibiotic resistance in the treatment of H. pylori infection is the principal reason for the failure of eradication regimens using the triple therapy. We reviewed the mechanisms of H. pylori antibiotic resistance and assessed the molecular tools commonly used to detect antibiotic resistance in Latin America. Most commonly reported molecular techniques were PCR and sequencing, as well as its variants PCR-RFLP and qPCR to detect the genes and mutations involved in the resistance to clarithromycin (CLR), amoxicillin (AMX), levofloxacin (LVX), tetracycline (TET), and metronidazole (MTZ). The mutation-associated resistance rates varied from 2.2% to 83.3% for CLA and 12% to 100% for LVX in 7 and 4 countries, respectively, whereas for MTZ the resistance frequency was between 50% to 100% in 4 countries. For TET and AMX, frequency of the resistance was in the range of 0% to 27% (5 and 3 countries, respectively). Molecular tools can be used for the rapid detection of resistance to CLR, LVX, and TET, whereas genotypic analysis is not appropriate to detect resistance to AMX and MTZ due to genomic changes found in the rdxA and pbp1A genes. The revision of the different molecular methods showed that qPCR and RFLP are the best tools to detect the resistance of H. pylori. Few molecular tools have been developed in Latin America to detect H. pylori resistance to antibiotics. More studies would be needed to understand better efficient strategies to prevent further emergence of antimicrobial resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study.
- Author
-
Chen, Xingcen, Peng, Ruyi, Peng, Dongzi, Liu, Deliang, and Li, Rong
- Subjects
- *
HELICOBACTER pylori infections , *NON-alcoholic fatty liver disease , *LIVER diseases , *HELICOBACTER pylori , *TRANSCRIPTOMES - Abstract
Background: The relationship between Helicobacter pylori (H. pylori) infection and metabolic dysfunction-associated steatotic liver disease (MASLD) has attracted increased clinical attention. However, most of those current studies involve cross-sectional studies and meta-analyses, and experimental mechanistic exploration still needs to be improved. This study aimed to investigate the mechanisms by which H. pylori impacts MASLD. Methods: We established two H. pylori-infected (Cag A positive and Cag A negative) mouse models with 16 weeks of chow diet (CD) or high-fat diet (HFD) feeding. Body weight, liver triglyceride, blood glucose, serum biochemical parameters, inflammatory factors, and insulin resistance were measured, and histological analysis of liver tissues was performed. Mouse livers were subjected to transcriptome RNA sequencing analysis. Results: Although H. pylori infection could not significantly affect serum inflammatory factor levels and serum biochemical parameters in mice, serum insulin and homeostatic model assessment for insulin resistance levels increased in CD mode. In contrast, H. pylori Cag A + infection significantly aggravated hepatic pathological steatosis induced by HFD and elevated serum inflammatory factors and lipid metabolism parameters. Hepatic transcriptomic analysis in the CD groups revealed 767 differentially expressed genes (DEGs) in the H. pylori Cag A + infected group and 1473 DEGs in the H. pylori Cag A- infected group, and the "nonalcoholic fatty liver disease" pathway was significantly enriched in KEGG analysis. There were 578 DEGs in H. pylori Cag A + infection combined with the HFD feeding group and 820 DEGs in the H. pylori Cag A- infected group. DEGs in the HFD groups were significantly enriched in "fatty acid degradation" and "PPAR pathway." Exploring the effect of different Cag A statuses on mouse liver revealed that fatty acid binding protein 5 was differentially expressed in Cag A- H. pylori. DEG enrichment pathways were concentrated in the "PPAR pathway" and "fatty acid degradation." Conclusions: Clinicians are expected to comprehend the impact of H. pylori on MASLD and better understand and manage MASLD. H. pylori infection may exacerbate the development of MASLD by regulating hepatic lipid metabolism, and the H. pylori virulence factor Cag A plays a vital role in this regulation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Helicobacter pylori infection increases the risk of dyslipidemia in Chinese diabetic Population: a retrospective cross-sectional study.
- Author
-
Yang, Chaoyu, You, Ningning, Chen, Yi, and Zhang, Jinshun
- Subjects
- *
HELICOBACTER pylori infections , *DYSLIPIDEMIA , *HELICOBACTER pylori , *LOGISTIC regression analysis , *CROSS-sectional method - Abstract
Background: In contemporary times, increased prevalence of Helicobacter pylori (H. pylori) infection and elevated dyslipidemia levels present substantial public health challenges. However, the relationship between H. pylori and dyslipidemia remains inconclusive. No studies have yet conducted a population-based classification to investigate the impact of H. pylori infection on dyslipidemia in individuals with diabetes. Methods: A retrospective cohort study was carried out on a total of 60,535 individuals who underwent health check-ups at the Health Examination Center in Taizhou Hospital from 2017 to 2022. Physical measurements, hematological markers and detection of H. pylori were gathered from all patients. The study population was further stratified into diabetic and non-diabetic groups for analysis. Results: H. pylori infection was found to be an autonomous risk factor for dyslipidemia based on the results of multivariate logistic regression analysis (OR = 1.13, 95% CI: 1.03–1.24). However, no notable effect on dyslipidemia in the non-diabetic group was observed. Furthermore, at the follow-up, the group with persistent negative showed a significantly lower incidence ratio of dyslipidemia compared to the group with persistent infection (P = 0.006). The persistent negative group exhibited a significantly higher rate of improvement in dyslipidemia compared to the new infection group (P = 0.038). Conclusions: In the diabetic population, the presence of H. pylori infection heightens the propensity for developing dyslipidemia. Therefore, the implementation of efficient eradication strategies for H. pylori infection could potentially lead to a decrease in the occurrence of dyslipidemia among individuals with diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Feco-prevalence, endoscopic pattern and associated factors of Helicobacter Pylori infection among symptomatic adult patients in Northern Tanzania.
- Author
-
Muhina, Ibrahim Ali Ibrahim, Sadiq, Abid M., Said, Fuad H., Raza, Faryal M., Gharib, Sarah K., Muhali, Sophia S., Costantine, Andrea R., Abdalla, Mulhati S., Shirima, Laura J., Chamba, Nyasatu G., Lyamuya, Furaha S., Mkwizu, Elifuraha W., Kilonzo, Kajiru G., Maro, Venance P., and Shao, Elichilia R.
- Subjects
- *
HELICOBACTER pylori infections , *HELICOBACTER pylori , *DUODENAL ulcers , *STOMACH ulcers , *ANTIGEN analysis , *BLOOD group antigens , *RH factor - Abstract
Background: Africa has consistently had the highest prevalence (70.1%) of H. pylori, and this has led to significant cases of dyspepsia, gastric cancers, and upper gastrointestinal bleeding. However, most studies have used sero-prevalence, which might not give the current state of the infection. Among the tests, the stool antigen test is simple, quick, and effective. The study aimed to determine the feco-prevalence, endoscopic pattern, and associated factors of H. pylori infection among symptomatic adult patients in Northern Tanzania. Materials and methods: A hospital-based, cross-sectional study was conducted from October 2022 to April 2023 among adults attending the gastroenterology clinic at Kilimanjaro Chistian Medical Centre. A systematic random sampling was used to select the participants with indications of undergoing esophagogastroduodenoscopy. Questionnaires, stool and blood samples, and endoscopy were used to collect variable data. Numerical and categorical variables were summarized into narrations and tables. Logistic regression was used to assess the factors associated with H. pylori. Results: The feco-prevalence of H. pylori was 43.4%. Chronic gastritis (51.1%) was the most common endoscopic pattern, whereas duodenal ulcers and gastric ulcers were significantly associated with H. pylori infection. Increasing in age (p <0.001) and blood group (p <0.001) were significantly associated with H. pylori infection in the adjusted analysis. Conclusion: The feco-prevalence of H. pylori is high in this setting. H. pylori stool antigen can be used as the initial workup for symptomatic patients before the initiation of proton pump inhibitors. Additionally, due to other causes of dyspepsia, it is advised that H. pylori stool antigen testing be part of the initial evaluation and esophagogastroduodenoscopy be considered in the absence of other alarm symptoms if symptoms persist despite an appropriate trial of medical therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Development of a pH‐strip‐based sensor for the detection of ammonia in exhaled breath as a promising method for the diagnosis of Helicobacter pylori infections.
- Author
-
Tsai, Ming‐Chang, Wang, Chi‐Chih, Chung, Hsieh‐Hsunh, Hsieh, Ping‐His, and Tsai, Hwei‐Yan
- Subjects
- *
HELICOBACTER pylori infections , *DIAGNOSIS methods , *FISH spoilage , *CARBOXYMETHYLCELLULOSE , *HELICOBACTER pylori , *DETECTORS - Abstract
The early detection and treatment of Helicobacter pylori infections can help prevent the formation of ulcers and development of gastric cancer in humans. The urea breath test (UBT) is a noninvasive test for diagnosing H. pylori. However, isotopic‐labeled UBT reagents are expensive and require specialized test equipment to detect isotopic CO2. In this study, the development of a user‐friendly, cost‐effective, and alternative method for diagnosing
H. pylori infections by detecting NH3 in exhaled breath is reported. A commercial disposable pH strip is modified with sodium carboxymethylcellulose to enhance its performance in gaseous environments. The modified pH strip exhibits compatibility with both acidic (HCl and CH3COOH) and alkaline (NH3) gases. Furthermore, the sensor monitors the production of NH3 resulting from fish spoilage for 72 h, highlighting its real‐time capabilities. The feasibility of employing this simple strip sensor to detect H. pylori infection in patients is investigated through in vitro experiments and preliminary clinical studies. The simple strip sensor is a promising alternative to the C‐13 UBT for detecting H. pylori infection. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
20. The immunopathogenesis of Helicobacter pylori-induced gastric cancer: a narrative review.
- Author
-
Shirani, Maryam, Shariati, Saeedeh, Bazdar, Monireh, Ghamnak, Faezeh Sojoudi, Moradi, Melika, Khozani, Reyhane Shams, Taki, Elahe, Arabsorkhi, Zahra, Heidary, Mohsen, and Eskandari, Dorsa Bahrami
- Subjects
HELICOBACTER pylori ,STOMACH cancer ,HELICOBACTER pylori infections ,HELICOBACTER ,BLOOD groups ,TOLL-like receptors - Abstract
Helicobacter pylori infection is a well-established risk factor for the development of gastric cancer (GC). Understanding the immunopathogenesis underlying this association is crucial for developing effective preventive and therapeutic strategies. This narrative review comprehensively explores the immunopathogenesis of H. pylori-induced GC by delving into several key aspects, emphasizing the pivotal roles played by H. pylori virulence factors, including cytotoxin-associated gene A (cagA) and vacuolating cytotoxin A (vacA), blood group antigen-binding adhesin (babA), and sialic acid binding adhesin (sabA). Moreover, the review focuses on the role of toll-like receptors (TLRs) and cytokines in the complex interplay between chronic infection and gastric carcinogenesis. Finally, the study examines the association between H. pylori evasion of the innate and adaptive immune response and development of GC. A comprehensive understanding of the immunopathogenesis of H. pylori-induced GC is essential for designing targeted interventions to prevent and manage this disease. Further research is warranted to elucidate the intricate immune responses involved and identify potential therapeutic targets to improve patient outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study.
- Author
-
Fallahi, Poupak, Ragusa, Francesca, Patrizio, Armando, Mazzi, Valeria, Botrini, Chiara, Elia, Giusy, Balestri, Eugenia, Barozzi, Emilio, Rugani, Licia, Palmisano, Elena, Cosenza, Maria Carla, Varricchi, Gilda, Ulisse, Salvatore, Benvenga, Salvatore, Ferrari, Silvia Martina, and Antonelli, Alessandro
- Subjects
GASTRIC diseases ,HYPOTHYROIDISM ,HELICOBACTER pylori infections ,H2 receptor antagonists ,PROTON pump inhibitors ,SCIENTIFIC observation - Abstract
Introduction: This is an observational and retrospective study, in which we have analyzed data from patients affected by gastric diseases (p) who have been treated with liquid L-T4 (L-LT4;84 p), or tablet L-T4 (T-LT4;120 p), for the replacement therapy of hypothyroidism. The aim of the study is to compare the stability of TSH [normal range, 0.3-3.5 mIU/ml] in these patients. Methods: All p assumed L-T4 30 minutes before breakfast. The types of gastric disease were: a) T-LT4 group: 74 chronic gastritis (CG); 4 gastrectomy for gastric cancer (GTx); 42 gastro-plastics (GP); b) L-LT4 group: 60 CG; 3 GTx; 21 GP (p>0.05). 66% p in T-LT4 group were chronically treated with proton pump inhibitors (PPI), against 51% in L-LT4 group (p>0.05). The frequency of Helicobacter Pylori infection was 17% in both T-LT4 and L-LT4 groups. The gender distribution, mean age and body weight were similar in the 2 groups (p>0.05). The mean L-T4 dosage in T-LT4 group at the basal evaluation was 1.22 +/-0.27 mg/kg/die, in the L-LT4 group 1.36+/-0.22 µg/kg/die (p>0.05). Results: At the basal evaluation the prevalence of patients with a TSH>3.5 µIU/mL in T-LT4 group was 36%, in L-LT4 group 46% (p<0.05). After adjustment of the dosage of the LT-4 therapy, the p were re-evaluated in an interval range of 5-9 months, for 4 times, during an overall period ranging from 23 to 31 months. At the first re-evaluation, the prevalence of p with a TSH>3.5 µIU/mL was 13% in both groups. At the second re-evaluation, the prevalence of p with a TSH>3.5 µIU/mL in T-LT4 group was 26%, in L-LT4 group 13% (p>0.05). At the third re-evaluation, the prevalence of p with TSH<3.5 mIU/mL in T-LT4 group was 19%, in L-LT4 group 9% (p=0.05). At the fourth and last re-evaluation, the prevalence of patients with a TSH>3.5 µIU/mL in T-LT4 group was 18%, in L-LT4 group 5% (p<0.05). Mean FT4 and FT3 circulating levels were not significantly different in the two group at each visit. Discussion: These data suggest that the liquid L-T4 formulation therapy can result in a more stable control of TSH levels in hypothyroid patients with gastric disorders in the long-term follow-up. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. A Novel Characteristic Gastric Mucus Named "Web-like Mucus" Potentially Induced by Vonoprazan.
- Author
-
Kaneko, Hiroaki, Sato, Hiroki, Suzuki, Yuichi, Ikeda, Aya, Kuwashima, Hirofumi, Ikeda, Ryosuke, Sato, Takeshi, Irie, Kuniyasu, Sue, Soichiro, and Maeda, Shin
- Subjects
- *
CHRONIC kidney failure , *HELICOBACTER pylori , *ALCOHOL drinking , *GASTRIC acid , *MUCUS , *HELICOBACTER pylori infections - Abstract
Background: In the absence of Helicobacter pylori (HP) infection, a characteristic gastric mucus adhesion may appear during the use of vonoprazan. We named this novel characteristic mucus "web-like mucus" (WLM). This study aimed to determine the incidence and risk factors for WLM. Methods: Between January 2017 and January 2022, 5665 patients were enrolled in this study. The patients were divided into a proton-pump inhibitor (PPI)-prescribed group (n = 2000), a vonoprazan-prescribed group (n = 268), and a no-PPI/vonoprazan-prescribed (n = 3397) group, and the presence of WLM was examined. After excluding four patients with autoimmune gastritis, the remaining 264 patients in the vonoprazan group were divided into WLM and non-WLM groups, and their clinical features were analyzed. Results: A total of 55 (21%) patients had WLM, all in the vonoprazan-prescribed group. There were no significant differences in factors such as, sex, age, chronic kidney disease, diabetes mellitus, HP eradication history, smoking, or alcohol consumption between the WLM and non-WLM groups. The median duration from the start of vonoprazan administration to the endoscopic detection of WLM was 2 (1–24) months. Conclusions: WLM appears to be a characteristic feature in patients treated with vonoprazan. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Comparison of vonoprazan bismuth‐containing triple therapy with quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: a prospective multicenter randomized controlled trial.
- Author
-
Liang, Jing Wen, Xiong, Si, Jia, Ye Gui, Xiao, Dan, Tan, Shi Yun, Cao, Ji Wang, Sun, Jun, Tian, Xia, Li, Shu Yu, Chen, Rui Hong, Ruan, Gui Zhen, Xiong, Jian Guang, Wang, Xiao Ming, Xu, San Ping, Qi, Li Ping, Liu, Yun Hua, Zhao, Yu Chong, Bai, Shu Ya, Chen, Wei, and Cao, Meng Die
- Subjects
- *
HELICOBACTER pylori infections , *HELICOBACTER , *HELICOBACTER pylori , *PEPTIC ulcer , *RANDOMIZED controlled trials , *DRUG resistance in bacteria - Abstract
Background and Aim Methods Results Conclusion Helicobacter pylori infection is linked to various gastrointestinal conditions, such as chronic active gastritis, peptic ulcers, and gastric cancer. Traditional treatment options encounter difficulties due to antibiotic resistance and adverse effects. Therefore, the aim of this study was to explore the effectiveness of a new treatment plan that combines vonoprazan (VPZ), amoxicillin, and bismuth for the eradication of H. pylori.A total of 600 patients infected with H. pylori were recruited for this multicenter randomized controlled trial. Patients treated for H. pylori elimination were randomly assigned at a 1:1 ratio to receive 14 days of vonoprazan‐based triple therapy (vonoprazan + amoxicillin + bismuth, group A) or standard quadruple therapy (esomeprazole + clarithromycin + amoxicillin + bismuth, group B). Compliance and adverse effects were tracked through daily medication and side effect records. All patients underwent a 13C/14C‐urea breath test 4 weeks after treatment completion.Intention‐to‐treat (ITT) and per‐protocol (PP) analyses revealed no substantial differences in H. pylori eradication rates between groups A and B (ITT: 83.7%
vs 83.2%; PP: 90.9%vs 89.7%). However, significant differences were observed in the assessment of side effects (13.7%vs 28.6%,P < 0.001). Specifically, group A had significantly fewer “bitter mouths” than group B did (3.7%vs 16.2%,P < 0.001).Triple therapy comprising vonoprazan (20 mg), amoxicillin (750 mg), and bismuth potassium citrate (220 mg) achieved a PP eradication rate ≥90%, paralleling standard quadruple therapy, and had fewer adverse events and lower costs (¥306.8vs ¥645.8) for treatment‐naive patients. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
24. The impact of diet, exercise, and sleep on Helicobacter pylori infection with different occupations: a cross-sectional study.
- Author
-
He, Shiwen, He, Xue, Duan, Yinglong, Luo, Yating, Li, Yuxuan, Li, Jing, Li, Ying, Yang, Pingting, Wang, Yaqin, Xie, Jianfei, Liu, Min, and SK Cheng, Andy
- Subjects
- *
HELICOBACTER pylori infections , *SLEEP , *CROSS-sectional method , *PERIODIC health examinations , *DIET - Abstract
Background: Associations between Helicobacter pylori infection and lifestyle factors vary greatly by geographic location. This study aims to evaluate the prevalence of Helicobacter pylori infection in the Hunan cohort of central China and analyze the associations between Helicobacter pylori infection and lifestyle factors in different occupations. Methods: This was a cross-sectional study. Participants who received an annual physical examination were invited. Helicobacter pylori infection was detected by the 13 C-urea breath test. Self-reported physical examination questionnaires were used to analyze participants' demographic information, diet, exercise status, and sleep situations. Results: 23254 participants finished this study. The Helicobacter pylori infection rate in the Hunan area was 25.8%, with the lowest prevalence in students (8.5%) and the highest prevalence in business managers (29.9%). The risk factors for Helicobacter pylori infection were marital status (divorced or married) (OR:1.16, 95%CI:1.090–1.234), overeating (OR:1.105, 95%CI: 1.001–1.220), and consumption of eggs (OR:1.047, 95%CI:1.004–1.092), animal viscera (OR: 1.077, 95%CI:1.014–1.144) and coffee (OR:1.074, 95%CI:1.019–1.132). Participants' education level (OR:0.911, 95%CI:0.881-0942), consumption of midnight snack (OR:0.926, 95%CI:0.877–0.977), and vegetable (OR:0.927, 95%CI: 0.884–0.972) were protective factors against Helicobacter pylori infection. Whether participants exercised regularly or had sleep problems had no significant effect on Helicobacter pylori infection. Different professionals showed significant differences in the rates of overeating, eating three meals on time, midnight snack, and consuming coffee, eggs, animal viscera, and vegetables > 3 times/week (P values < 0.05). Conclusions: Helicobacter pylori infection showed a significant relationship with dietary factors, but not significantly with sleep and exercise factors. Different occupations showed different dietary tendencies related to Helicobacter pylori infection. The design of an occupation-based Helicobacter pylori screening and prevention program is supported. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Implications of silver nanoparticles for H. pylori infection: modulation of CagA function and signaling.
- Author
-
Hochvaldova, Lucie, Posselt, Gernot, Wessler, Silja, Kvítek, Libor, and Panáček, Aleš
- Subjects
HELICOBACTER pylori ,SILVER nanoparticles ,HELICOBACTER pylori infections ,CONCENTRATION functions ,RAMAN scattering ,WESTERN immunoblotting - Abstract
Background: Helicobacter pylori infection poses a significant health burden worldwide, and its virulence factor CagA plays a pivotal role in its pathogenesis. Methods: In this study, the interaction between H. pylori-infected AGS cells and silver nanoparticles (AgNPs) was investigated, with a focus on the modulation of CagA-mediated responses, investigated by western blotting. Both, the dosedependent efficacy against H. pylori (growth curves, CFU assay) and the impact of the nanoparticles on AGS cells (MTT assay) were elucidated. Results: AGS cells infected with H. pylori displayed dramatic morphological changes, characterized by elongation and a migratory phenotype, attributed to CagA activity. Preincubation of H. pylori with AgNPs affected these morphological changes in a concentration-dependent manner, suggesting a correlation between AgNPs concentration and CagA function. Conclusion: Our study highlights the nuanced interplay between host-pathogen interactions and the therapeutic potential of AgNPs in combating H. pylori infection and offers valuable insights into the multifaceted dynamics of CagA mediated responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Obesity, abdominal obesity, metabolic obesity phenotypes, and Helicobacter pylori infection: results from NHANES 1999–2000.
- Author
-
Chen, Danni, Wang, Shiling, Yang, Wei, Lu, Hong, and Ren, Qian
- Subjects
- *
HELICOBACTER pylori infections , *HEALTH & Nutrition Examination Survey , *OBESITY - Abstract
Background: Recent studies on the association between Helicobacter pylori (H. pylori) infection and obesity have reported conflicting results. Therefore, the purpose of our study was to investigate the association of obesity, abdominal obesity, and metabolic obesity phenotypes with H. pylori infection. Methods: A cross-sectional study of 1568 participants aged 20 to 85 was conducted using the National Health and Nutrition Examination Survey (NHANES) cycle 1999–2000. Logistic regression models were employed to evaluate the association of general obesity as defined by body mass index (BMI), abdominal obesity as defined by waist circumference (WC) and waist-height ratio (WHtR), and metabolic obesity phenotypes with H. pylori seropositivity. Subgroup analyses stratified by age were conducted to explore age-specific differences in this association. Results: After grouping individuals according to their WHtR, the prevalence rate of WHtR ≥ 0.5 in H. pylori-seropositive participants was significantly higher than that in H. pylori-seronegative participants (79.75 vs. 68.39, P < 0.001). The prevalence of H. pylori seropositivity in non-abdominal obesity and abdominal obesity defined by WHtR was 24.97% and 31.80%, respectively (P < 0.001). In the subgroup analysis, the adjusted association between abdominal obesity, as defined by the WHtR, and H. pylori seropositivity was significant in subjects aged < 50 years (OR = 2.23; 95% CI, 1.24–4.01; P = 0.01) but not in subjects aged ≥ 50 years (OR = 0.84; 95% CI, 0.35–1.99; P = 0.66). Subjects older than 50 years old had an OR (95% CI) for metabolically healthy obesity of 0.04 (0.01–0.35) compared with the control group. H. pylori seropositivity was consistently not associated with obesity as defined by BMI. Conclusions: Abdominal obesity, as defined by the WHtR, was associated with H. pylori infection in subjects aged ≤ 50 years. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Peptic ulcer disease.
- Author
-
Almadi, Majid A, Lu, Yidan, Alali, Ali A, and Barkun, Alan N
- Subjects
- *
PEPTIC ulcer , *FIBRINOLYTIC agents , *PATIENT selection , *HEARTBURN , *PROTON pump inhibitors , *DISEASE management , *HELICOBACTER pylori infections - Abstract
Annual prevalence estimates of peptic ulcer disease range between 0·12% and 1·5%. Peptic ulcer disease is usually attributable to Helicobacter pylori infection, intake of some medications (such as aspirin and non-steroidal anti-inflammatory medications), or being critically ill (stress-related), or it can be idiopathic. The clinical presentation is usually uncomplicated, with peptic ulcer disease management based on eradicating H pylori if present, the use of acid-suppressing medications—most often proton pump inhibitors (PPIs)—or addressing complications, such as with early endoscopy and high-dose PPIs for peptic ulcer bleeding. Special considerations apply to patients on antiplatelet and antithrombotic agents. H pylori treatment has evolved, with the choice of regimen dictated by local antibiotic resistance patterns. Indications for primary and secondary prophylaxis vary across societies; most suggest PPIs for patients at highest risk of developing a peptic ulcer, its complications, or its recurrence. Additional research areas include the use of potassium-competitive acid blockers and H pylori vaccination; the optimal approach for patients at risk of stress ulcer bleeding requires more robust determinations of optimal patient selection and treatment selection, if any. Appropriate continuation of PPI use outweighs most possible side-effects if given for approved indications, while de-prescribing should be trialled when a definitive indication is no longer present. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Up-regulation of MiR-146a-5p and MiR-155-5p are Involved in Inflammatory Immune Dysregulation in Patients with Hashimoto's Thyroiditis and Helicobacter Pylori Infection.
- Author
-
Rashad, Nearmeen M., Wahba, Mohamed O., Elshamy, Abdelmonem Mohamed, Ateya, Marwa Abdel-monem, Soliman, Manar H., Abdelnour, Hanim M., and EL Hawary, Amr Talaat
- Subjects
- *
AUTOIMMUNE thyroiditis , *HELICOBACTER pylori infections , *GENE expression , *THYROID diseases , *INDEPENDENT variables - Abstract
Helicobacter pylori (HP) is an infection related to metabolic and autoimmune disease Hashimoto thyroiditis (HT). HP-modified microRNA (miRNA) expression leads to various disorders. We aimed to evaluate circulatory miR-146a-5p and miR-155-5p expression in HT and to investigate their correlations with the clinical profile of HT and HP infection. Methods: We enrolled 100 subjects; 50 participants as healthy control and 50 patients with HT. The diagnosis of HP-infection by-HP antigen in stool and antibodies against cytotoxic-associated gene A (Cag-A). We tested serum antibodies against thyroid antigens. We used Quantitative real-time RT-PCR for the assessment of serum miR-146a-5p and miR-155-5p. Results: Among 100 studied participants, patients inf*. Concerning had significantly higher values of miR-146a-5p (3.94±0.8), compared to HT patients without HP infection (1.84±0.3) and control group (0.98±0.1), p value<0.001*. Concerning miR-155-5p, there were statistically significant higher values in HP infection (3.61±2.2) compared to HT patients without HP infection (1.91±1.1) and control group (0.90±0.35), p value<0.001*. There were significantly positive correlations with nausea, vomiting, heartburn, anti-TPO, anti-TG, TSH, HP antigen, and Cag-A. On the opposing, they were negatively correlated with FT3 and FT4. linear regression analyses revealed that the only variables independently associated with miR-146a-5p were anti-TPO and FT4. Whereas the only variables independent associated with miR-155-5p were anti-TPO and FT3, p value<0.001*. Conclusion: miR-146a-5p and miR-155-5p overexpressed in patients with HT, more specifically in patients infected by HP and they were significantly correlated to gastrointestinal symptoms thyroid dysfunction, and autoimmunity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Prevalence of Helicobacter pylori Infection and Efficacy of Bismuth Quadruple and Levofloxacin Triple Eradication Therapies: A Retrospective Analysis.
- Author
-
Serena, Patricia, Popa, Alexandru, Bende, Renata, Miutescu, Bogdan, Mare, Ruxandra, Borlea, Andreea, Aragona, Giovanni, Groza, Andrei Lucian, Serena, Luca, Popescu, Alina, Sporea, Ioan, and Sirli, Roxana
- Subjects
- *
HELICOBACTER pylori infections , *BARRETT'S esophagus , *HELICOBACTER pylori , *STOMACH ulcers , *STOMACH cancer - Abstract
Helicobacter pylori (H. pylori) infection is a widespread global health issue and a primary cause of diseases like gastritis, gastroduodenal ulcers, and gastric cancer. This study examines the prevalence of H. pylori infection in patients undergoing upper endoscopy and assesses the efficacy of bismuth quadruple therapy (BQT) and levofloxacin triple therapy. A retrospective analysis of 507 gastroscopies was conducted, with indications including epigastric pain, heartburn, postprandial fullness, early satiation, and regurgitation. Rapid urease tests were performed, and endoscopic findings documented. Two treatment regimens were used: BQT as the first-line therapy and levofloxacin triple therapy as the second-line. Of the 507 patients, 68.8% were infected with H. pylori. Gastric ulcer patients had significantly higher H. pylori prevalence compared to those with small polyps, Barrett's esophagus, or normal endoscopy. Among the 310 patients who participated in follow-up interviews, 11.9% did not initiate therapy and 5.1% discontinued due to intolerance. The overall eradication rate was 88.6%, with BQT showing a higher eradication rate (89.4%) compared to levofloxacin triple therapy (83.8%). The study highlights the high prevalence of H. pylori among patients with gastrointestinal symptoms and the effectiveness of BQT as a first-line treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Ultra‐Processed food intake and risk of Helicobacter pylori infection: A case–control study.
- Author
-
Ebrahimi, Zohreh, Shateri, Zainab, Nouri, Mehran, Sikaroudi, Masoumeh Khalighi, Masoodi, Mohsen, Shidfar, Farzad, and Hejazi, Mahdi
- Subjects
- *
HELICOBACTER pylori infections , *FOOD consumption , *HELICOBACTER pylori , *PROCESSED foods , *CASE-control method , *BODY mass index - Abstract
The components in our food are known as one of the important risk factors for the development of Helicobacter pylori (H. pylori) infection. A balanced diet, rich in fruits and vegetables, and free of fat, sugar, and salt, might protect people from the consequences of H. pylori infection. Therefore, the purpose of this study was to investigate the associations between ultra‐processed foods (UPFs) intake and the risk of H. pylori infection. The case–control study was conducted to assess the intake of UPFs in patients with H. pylori infection compared with healthy individuals. The dietary data of the contributors were collected by a validated food frequency questionnaire (FFQ). To estimate the UPFs intake, the classification of the NOVA food group was utilized. The associations of intake UPFs with H. pylori infection were assessed using binary logistic regression. Finally, dietary data of 150 cases and 302 controls (mean age: 39.5 ± 10.95 years) were analyzed. UPFs intake was associated with higher risk of H. pylori infection (odds ratio (OR) = 1.71; 95% confidence interval (CI): 1.05, 2.79). The association remained constant after adjustment for age, body mass index (BMI), sex, energy intake, physical activity, smoking, and alcohol status (OR = 2.17; 95% CI: 1.22, 3.86). Our data declare that UPFs consumption could have a role in increasing the likelihood of the risk of H. pylori infection. To confirm the current findings, prospective studies are suggested. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Determining the frequency of Helicobacter pylori in children with chronic kidney failure and its relationship to gastrointestinal symptoms.
- Author
-
Nezhad, Behgol Nemati, Allahverdi, Bahar, Motamed, Farzaneh, Djalalinia, Shirin, Askarian, Fahimeh, Fahimi, Daryoush, Bazargani, Behnaz, Abbasi, Arash, and Moghtaderi, Mastaneh
- Subjects
- *
CHRONIC kidney failure , *KIDNEY failure , *HELICOBACTER pylori , *HELICOBACTER pylori infections , *SYMPTOMS , *NEUROGENIC bladder , *PEDIATRIC nephrology - Abstract
Key Clinical Message: As there is no significant mutual relationship between Helicobacter pylori infection and chronic kidney disease in children, its routine study is not justified and is recommended only in symptomatic cases. Children suffering from chronic kidney disease (CKD) often complain of indigestion but, if it is accompanied by abdominal pain, it is necessary to investigate and rule out Helicobacter pylori infection to confirm functional dyspepsia. Epidemiological studies in adults have conflicting results regarding the association between Helicobacter pylori infection and CKD. In this study, we determined the prevalence of H. pylori in children with kidney failure and its relationship to their gastrointestinal symptoms. In this retrospective study, 54 children with chronic kidney failure admitted to the hemodialysis ward of the Children's Medical Center, Tehran, Iran between 2012 and 2020 were studied. The mean age of our patients was 11.89 ± 3.99 years and their sex distribution was equal. H. pylori infection was reported in only three patients with 5.6%. Based on our findings, epigastric pain in children was the most common gastrointestinal symptom (70.4%). Among all patients, three patients (5.6%) died, all of them were male (P = 0.075). The most prevalent underlying cause of kidney failure in our patients was neurogenic bladder. We did not find any significant relationship between the increased risk of chronic kidney failure and co‐infection with H. pylori. Investigating the cause of epigastric pain and looking for H. pylori is very important in CKD children under hemodialysis because if they receive a transplant the possibility of gastrointestinal complications will be increased with the use of steroid and immunosuppressive drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days.
- Author
-
Ding, Yu-Ming, Duan, Miao, Han, Zhong-Xue, Song, Xiao-Hui, Zhang, Feng-Lan, Wang, Zhi, Ning, Zhang, Zeng, Shu-yan, Kong, Qing-Zhou, Zhang, Wen-Lin, Liu, Jing, Wan, Meng, Lin, Min-Juan, Lin, Bo-Shen, Nan, Xue-ping, Wang, Hui, Li, Yue-Yue, Zuo, Xiu-Li, and Li, Yan-Qing
- Subjects
- *
HELICOBACTER pylori infections , *HELICOBACTER pylori , *CLINICAL trials , *TERMINATION of treatment , *PATIENT compliance , *BREATH tests - Abstract
Background: Bismuth-containing quadruple therapy is the first-line treatment for eradicating Helicobacter pylori (H. pylori). The optimal duration for H. pylori eradication using bismuth-containing quadruple therapy remains controversial. Therefore, we aimed to compare the clinical effects of the 10- and 14-day bismuth-containing quadruple treatment regimen to eradicate H. pylori. Methods: Treatment-naïve patients with H. pylori infection (n = 1300) were enrolled in this multicenter randomized controlled study across five hospitals in China. They were randomized into 10- or 14-day treatment groups to receive bismuth-containing quadruple therapy as follows: vonoprazan 20 mg twice daily; bismuth 220 mg twice daily; amoxicillin 1000 mg twice daily; and either clarithromycin 500 mg twice daily or tetracycline 500 mg four times daily. At least 6 weeks after treatment, we performed a 13C-urea breath test to evaluate H. pylori eradication. Results: The per-protocol eradication rates were 93.22% (564/605) and 93.74% (569/607) (p < 0.001) and the intention-to-treat eradication rates were 88.62% (576/650) and 89.38% (581/650) (p = 0.007) for the 10- and 14-day regimens, respectively. Incidence of adverse effects was lower in patients who received 10- vs. 14 days of treatment (22.59% vs. 28.50%, p = 0.016). We observed no significant differences in the compliance to treatment or the discontinuation of therapy because of severe adverse effects between the groups. Conclusion: Compared with the 14-day bismuth-containing quadruple regimens, the 10-day regimen demonstrated a non-inferior efficacy and lower incidence of adverse effects. Therefore, the 10-day regimen is safe and tolerated and could be recommended for H. pylori eradication (NCT05049902). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis.
- Author
-
Mantovani, Alessandro, Lando, Maria Giovanna, Borella, Nicolò, Scoccia, Enrico, Pecoraro, Barbara, Gobbi, Federico, Bisoffi, Zeno, Valenti, Luca, Tilg, Herbert, Byrne, Christopher D., and Targher, Giovanni
- Subjects
- *
HELICOBACTER pylori infections , *LIVER diseases , *HELICOBACTER pylori , *CROSS-sectional method , *NON-alcoholic fatty liver disease - Abstract
Background: Recent observational studies examining the association between Helicobacter pylori infection and the risk of metabolic dysfunction-associated steatotic liver disease (MASLD) have reported conflicting results. We performed a metaanalysis to quantify the magnitude of the association between H. pylori infection and the risk of MASLD. Methods: We systematically searched three large electronic databases to identify eligible observational studies (published up to 30 November 2023) in which liver biopsy, imaging methods or blood-based biomarkers/scores were used for diagnosing MASLD. Data from selected studies were extracted, and meta-analysis was performed using common and random-effects modelling. Statistical heterogeneity among published studies, subgroup analyses, meta-regression analyses and publication bias were assessed. Results: A total of 28 observational studies (24 cross-sectional and 4 longitudinal studies) were identified, including 231291 middle-aged individuals of predominantly Asian ethnicity (~95%). Meta-analysis of cross-sectional studies showed that H. pylori infection was significantly associated with a small increase in the risk of prevalent MASLD (n = 24 studies; random-effects odds ratio 1.11, 95% CI 1.05-1.18; I² = 63%). Meta-analysis of data from longitudinal studies showed that H. pylori infection was significantly associated with an increased risk of developing incident MASLD over a mean 5-year follow-up (n=4 studies; random-effects odds ratio 1.20, 95%CI 1.081.33; I² = 44%). Sensitivity analyses did not modify these results. The funnel plot did not reveal any significant publication bias. Conclusions: H. pylori infection is associated with a mildly increased risk of prevalent and incident MASLD. Further well-designed prospective and mechanistic studies are required to better decipher the complex link between H. pylori infection and the risk of MASLD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Risk of Ischemic Stroke in Relation to Helicobacter pylori Infection and Eradication Status: A Large-Scale Prospective Observational Cohort Study.
- Author
-
Eun-Bi Jeon, Nayoung Kim, Beom Joon Kim, In-Chang Hwang, Sang Bin Kim, Ji-Hyun Kim, Yonghoon Choi, Yu Kyung Jun, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, and Soyeon Ahn
- Subjects
- *
ISCHEMIC stroke , *HELICOBACTER pylori infections , *COHORT analysis , *SCIENTIFIC observation , *HELICOBACTER pylori - Abstract
Background/Aims: A few studies have suggested the association between Helicobacter pylori (HP) infection and ischemic stroke. However, the impact of HP eradication on stroke risk has not been well evaluated. This study aimed to assess the influence of HP eradication on the incidence of ischemic stroke, considering the potential effect of sex. Methods: This prospective observational cohort study was conducted at Seoul National University Bundang Hospital, from May 2003 to February 2023, and involved gastroscopy-based HP testing. Propensity score (PS) matching was employed to ensure balanced groups by matching patients in the HP eradicated group (n=2,803) in a 3:1 ratio with patients in the HP non-eradicated group (n=960). Cox proportional hazard regression analysis was used to evaluate the risk of ischemic stroke. Results: Among 6,664 patients, multivariate analysis after PS matching indicated that HP eradication did not significantly alter the risk of ischemic stroke (hazard ratio, 0.531; 95% confidence interval, 0.221 to 1.270; p=0.157). Sex-specific subgroup analyses, both univariate and multivariate, did not yield statistically significant differences. However, Kaplan-Meier analysis revealed a potential trend: the females in the HP eradicated group exhibited a lower incidence of ischemic stroke than those in the HP non-eradicated group, although this did not reach statistical significance (p=0.057). Conclusions: This finding suggests that HP eradication might not impact the risk of ischemic stroke. However, there was a trend showing that females potentially had a lower risk of ischemic stroke following HP eradication, though further investigation is required to establish definitive evidence. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Clinical analysis of the effect of helicobacter pylori infection on immune function in children with peptic ulcer.
- Author
-
Yongnan Teng, Qingwei Dong, Sisi Zhang, Songsong Chen, and Chen Li
- Subjects
- *
HELICOBACTER pylori infections , *PEPTIC ulcer , *LYMPHOCYTE subsets , *T cells , *CHILDREN'S hospitals - Abstract
Objective: To study whether children with peptic ulcer would have abnormalities in cellular and humoral immune functions, and whether Helicobacter pylori (Hp) infection would affect the immune function of children with peptic ulcer. Methods: This is a retrospective study. The subjects of study were 72 children with diagnosed and cured peptic ulcer (ulcer group), and 50 healthy children with physical examination (control group) at Baoding Hospital, Beijing Children's Hospital Affiliated to Capital Medical University from June 2020 to December 2022. Further detection was conducted on T lymphocyte subsets (CD3+, CD4+, CD8+, and CD4+/CD8+ ratio) and immunoglobulin levels. Results: Of the 72 children with peptic ulcer, 53(73.6%) were positive for Hp (Hp-positive group) and 19 (26.4%) were negative (Hp-negative group). The levels of CD3+, CD4+, and CD4+/CD8+ ratio in the control group were significantly higher than those in the ulcer group, with statistically significant difference (P<0.05); while the level of IgG in the control group was lower than that in the ulcer group, with statistically significant difference (P<0.05). Meanwhile, there were statistically significant differences in that the levels of CD3+, CD4+ and CD8+ were increased in Hp-positive group than those in Hp-negative group before treatment (P<0.05); while CD4+/CD8+ ratio was lower in the former group than that in the latter group, with statistically significant difference (P<0.05). Conclusion: Hp infection can induce the elevation of T lymphocyte subsets. The development of peptic ulcer has an intimate association with the disorder of cellular and humoral immune functions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Helicobacter pylori Infection in Children With Cerebral Palsy: A Cross-Sectional Study.
- Author
-
Ismael, Sally M., Atia, Dina S., Atlam, Salwa A., Eltoukhy, Abeer A., and Darwish, Amira Hamed
- Subjects
- *
HELICOBACTER pylori infections , *CHILDREN with cerebral palsy , *HELICOBACTER pylori , *ENZYME-linked immunosorbent assay , *CROSS-sectional method , *PEDIATRIC neurology - Abstract
Children with cerebral palsy (CP) frequently have associated disorders and complications, including gastrointestinal problems. Helicobacter pylori is a common infection worldwide, frequently associated with gastrointestinal manifestations. To estimate the prevalence of H. pylori infection in children with CP , a cross-sectional study over an eight-month period was performed in the pediatric neurology outpatient clinic of Tanta University Hospital. The study included 100 patients with CP aged two to 17 years. All patients were tested for H. pylori antigen in stool by enzyme-linked immunosorbent assay. The mean age of studied children with CP was 7.03 ± 4.1 years; there were 57 males and 43 females. Spastic quadriplegic CP was the most common type of CP (34%). Forty-five children with CP were positive for H. pylori antigen in stool. Intellectual disability (ID), low sociodemographic scoring system, semisolid diet, and Eating and Drinking Ability Classification System (EDACS) levels 4 and 5 were significant predictors of H. pylori infection (odds ratio of 1.86, 2.63, 12, and 1.77, respectively, P < 0.05). Vomiting, abdominal pain, and gastrointestinal tract bleeding were significantly more frequent in H. pylori -infected children with CP than noninfected children with CP (P value < 0.05) H. pylori is a relatively common infection among children with CP. The main risk factors for H. pylori infection were low socioeconomic level, ID, semisolid diet, and EDACS levels 4 and 5. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. "Presence of Helicobacter pylori infection in resected specimens of gallbladder with different lesions at a tertiary care centre".
- Author
-
Ansari, Faiza, Iqbal, Javed, Agrawal, Megha, Jaiswal, Pooja, and Singh, Priyanka
- Subjects
- *
HELICOBACTER pylori infections , *GALLBLADDER , *HELICOBACTER pylori , *TERTIARY care , *GALLSTONES , *MEDICAL care costs - Abstract
Background: The burden of chronic cholecystitis and cholelithiasis extends beyond individual health outcomes and poses a considerable medical and economic burden on society. The costs associated with diagnosis, treatment, and potential complications of gallstone diseases contribute significantly to healthcare expenditures. Material & methods: This study adopts an Observational Analytical Study design, aiming to investigate the presence of H. pylori infection in resected gallbladder specimens with various lesions, including chronic inflammation, dysplastic changes, and malignant lesions with the help of warthin starry stain. Results: The data presented highlighted the association between Helicobacter pylori (H. pylori) infection status and the occurrence of non-neoplastic and neoplastic lesions. Among individuals with H. pylori positivity, non-neoplastic lesions were observed in approximately 21% of cases, while neoplastic lesions were identified in 4% of cases. Conclusion: The intricate relationship between H. pylori infection, gut microbiota composition, and gall bladder diseases investigates the potential impact of microbiome alterations on gallstone formation, chronic inflammation, and neoplastic transformations, paving the way for microbiome-targeted interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
38. Histopathological study of gastric cancer: a retrospective study.
- Author
-
Toppo A., Gharei R., Dutta G., and Sahoo S.
- Subjects
- *
STOMACH cancer , *MUCINOUS adenocarcinoma , *HISTOPATHOLOGY , *DEMOGRAPHIC characteristics , *AGE groups , *HELICOBACTER pylori infections - Abstract
Background: Gastric cancer is one of the common causes of cancer, especially among older males. Its incidence and mortality vary greatly by geography and are highly dependent on food and Helicobacter pylori infection. Objective: To describe the general pattern of primary gastric cancers in the western region of Odisha and compare the findings of patients' age, sex, gross features, and histological types to findings from other studies. Methods: Over a five-year period, 82 cases of stomach cancer were included in this descriptive record-based study conducted in the Department of Pathology at VSSIMSAR, Burla. The diagnosis of gastric cancer was made on hematoxylin and eosin-stained sections and were categorized according to the WHO classification system. Results: Out of 82 cases of Gastric cancer, 51 (62.19%) were males and 31 (37.80%) were females, with a male-to-female ratio of 1.6:1. The most common age group was 51-60 (40.24%), followed by 61-70 (23.17%). Pyloric antrum (73.17%) was the commonest site involved, followed by corpus (17.07%), and cardia (2.43%). Grossly, the most common type was an ulcerative lesion. Microscopically, according to WHO classification, tubular adenocarcinomas were the most common (75.6%), followed by signet ring cell carcinoma (12.19%), poorly cohesive carcinoma, non-signet ring cell type (7.31%), and mucinous carcinoma (2.43%). Conclusion: The frequency of stomach cancers in the western region of Odisha exhibited demographic characteristics as well as gross features and histological types were comparable to those documented in other parts of the world. [ABSTRACT FROM AUTHOR]
- Published
- 2024
39. An antibiotic-free platform for eliminating persistent Helicobacter pylori infection without disrupting gut microbiota.
- Author
-
Lai, Yongkang, Zhang, Tinglin, Yin, Xiaojing, Zhu, Chunping, Du, Yiqi, Li, Zhaoshen, and Gao, Jie
- Subjects
HELICOBACTER pylori infections ,GUT microbiome ,HELICOBACTER pylori ,MATRIX metalloproteinases ,DRUG resistance - Abstract
Helicobacter pylori (H. pylori) infection remains the leading cause of gastric adenocarcinoma, and its eradication primarily relies on the prolonged and intensive use of two antibiotics. However, antibiotic resistance has become a compelling health issue, leading to H. pylori eradication treatment failure worldwide. Additionally, the powerlessness of antibiotics against biofilms, as well as intracellular H. pylori and the long-term damage of antibiotics to the intestinal microbiota, have also created an urgent demand for antibiotic-free approaches. Herein, we describe an antibiotic-free, multifunctional copper-organic framework (HKUST-1) platform encased in a lipid layer comprising phosphatidic acid (PA), rhamnolipid (RHL), and cholesterol (CHOL), enveloped in chitosan (CS), and loaded in an ascorbyl palmitate (AP) hydrogel: AP@CS@Lip@HKUST-1. This platform targets inflammatory sites where H. pylori aggregates through electrostatic attraction. Then, hydrolysis by matrix metalloproteinases (MMPs) releases CS-encased nanoparticles, disrupting bacterial urease activity and membrane integrity. Additionally, RHL disperses biofilms, while PA promotes lysosomal acidification and activates host autophagy, enabling clearance of intracellular H. pylori. Furthermore, AP@CS@Lip@HKUST-1 alleviates inflammation and enhances mucosal repair through delayed Cu
2+ release while preserving the intestinal microbiota. Collectively, this platform presents an advanced therapeutic strategy for eradicating persistent H. pylori infection without inducing drug resistance. A multifunctional antibiotic-free platform that could eradicate Helicobacter pylori with planktonic, intracellular, and biofilm forms while also promoting gastric mucosal repair without disrupting intestinal flora homeostasis. [Display omitted] [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
40. Simultaneous Detection of Helicobacter pylori and Clarithromycin Resistance Mutations Using RAA-CRISPR/Cas13a Assay.
- Author
-
Yan, Kuocheng, Wang, Xiaohui, Han, Yao, Tian, Yuan, Niu, Mengwei, Dong, Xue, Li, Xiaowei, Li, Hao, and Sun, Yansong
- Subjects
HELICOBACTER pylori ,HELICOBACTER pylori infections ,NUCLEIC acids ,CLARITHROMYCIN ,STOMACH cancer - Abstract
Background: Infection caused by Helicobacter pylori (H. pylori) affects approximately 50% of the global population. It is a major pathogenic factor for chronic gastritis and gastric cancer. Besides, the resistance to antibiotics such as clarithromycin could reduce the eradication rate. Currently, there is an urgent need for a swift, easy to perform, and highly sensitive detection method for H. pylori and clarithromycin resistance. Methods: We used FAM/Digoxin labeled primers to amplify specific H. pylori 23S rRNA fragments by Recombinase Aided Amplification (RAA), and resistance mutations were distinguished using CRISPR/Cas13a system combined with lateral flow strip. Twenty-eight saliva samples were analyzed using qPCR, gene sequencing and this method to evaluate the detection efficiency. Results: We developed a simultaneous detection method for H. pylori and clarithromycin resistance mutations named sensitive H. pylori easy-read dual detection (SHIELD). The results showed both A2142G and A2143G mutant DNAs causing clarithromycin resistance could be distinguished from the wild type with a concentration of 50 copies/μL, and no cross-reaction with other 5 common gastrointestinal bacteria was observed. For the detection of H. pylori in 28 saliva samples, the positive predictive value of this method was 100% (19/19) in comparison with qPCR. For detecting clarithromycin resistance, the positive predictive value of this method was 84.6% (11/13) compared with gene sequencing. Conclusion: SHIELD assay showed high sensitivity and specificity in detecting H. pylori and clarithromycin resistance mutations. It could be a potential measure in the rapid detection of H. pylori, large-scale screening and guiding clinical medication. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Real-World Situation of Eradication Regimens and Risk Factors for Helicobacter pylori Treatment in China: A Retrospective Single-Center Study.
- Author
-
Cheng, Jianping, Fan, Chanjuan, Li, Zhen, Dong, Zhaojing, Zhao, Xiaolin, Cai, Yong, Ding, Haiou, Dou, Yan, and Zhang, Xiaomei
- Subjects
HELICOBACTER pylori ,PROTON pump inhibitors ,HELICOBACTER pylori infections ,TREATMENT failure ,AMOXICILLIN ,MULTIVARIATE analysis - Abstract
Objectives: The success rate of Helicobacter pylori (H. pylori) eradication in China is declining. The aim of this study was to evaluate eradication outcomes in clinical practice and identifies factors contributing to treatment failure. Methods: A retrospective review was conducted on patients treated for H. pylori infection with 14-day bismuth-containing quadruple therapy at a Beijing medical center from January 2020 to December 2023. We analyzed demographic and clinical data, eradication rates across regimens, and performed multivariate analysis to pinpoint predictors of failure. Results: Out of 3340 participants, 2273 (68.1%) achieved eradication. Amoxicillin-based combinations (69.2%) outperformed other antibiotic regimens (58.9%, p < 0.001), with amoxicillin plus doxycycline reaching a 71.4% success rate. Esomeprazole-based regimens were more effective (73.6%) than other PPI regimens (65.2%, p = 0.001), notably, a rabeprazole, amoxicillin, doxycycline, and bismuth combination had an 80.0% success rate. Age, gender, and smoking and drinking were significant eradication failure predictors. Conclusion: In real-world settings, 14-day amoxicillin and esomeprazole-based quadruple regimens have been demonstrated to be more effective than other regimens. Age, gender, and lifestyle habits are identified as independent risk factors for eradication failure. Registration: This study was registered in the Chinese Clinical Trial Registry on 08/01/2024 (clinical trial registration number: ChiCTR2400079647). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Detection of Clarithromycin Resistance in Helicobacter pylori Using MmaxSure™ H. pylori & ClaR Assay.
- Author
-
Kim, Ilsoo, Shin, Yu Ri, Kim, Joon Sung, Kim, Byung-Wook, Maeng, Lee-So, and Kim, Jung Min
- Subjects
HELICOBACTER pylori infections ,HELICOBACTER pylori ,CLARITHROMYCIN ,DIAGNOSTIC use of polymerase chain reaction ,POLYMERASE chain reaction ,SEQUENCE analysis - Abstract
Introduction: Clarithromycin resistance is a crucial factor in the eradication of Helicobacter pylori. This study aimed to evaluate the performance of MmaxSure™ H. pylori & ClaR Assay (MmaxSure™) in the diagnosis and detection of clarithromycin resistance in H. pylori. Methods: Subjects who underwent esophagogastroduodenoscopy between April 2020 and October 2022 were enrolled. The diagnostic performances of MmaxSure™ and dual priming oligonucleotide (DPO)-based multiplex polymerase chain reaction (PCR) were compared with the rapid urease test and culture. Secondary gene sequencing analysis was performed in discordant cases of PCR tests. Results: A total of 156 gastric biopsy samples were analyzed. In H. pylori detection, MmaxSure™ showed a 95.9% sensitivity (95% CI: 90.6–98.6), a 42.7% specificity (95% CI: 26.3–60.7), and a kappa value of 0.457. For the detection of A2143G mutation samples, MmaxSure™ showed a 91.2% sensitivity (95% CI: 76.3–98.1), a 93.4% specificity (95% CI: 87.5–97.1), and a kappa value of 0.804. There were a total of 10 discordant cases compared to gene sequencing in A2143G mutation detection for MmaxSure™. Conclusion: In this study, MmaxSure™ showed comparable diagnostic performance to DPO-PCR in the detection of the H. pylori and A2143G mutation. Further research is needed to confirm the clinical effectiveness of the MmaxSure™ assay in H. pylori eradication. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Helicobacter pylori Infection: A 40-Year Journey through Shifting the Paradigm to Transforming the Management.
- Author
-
Malfertheiner, Peter, Schulz, Christian, and Hunt, Richard H.
- Subjects
HELICOBACTER pylori infections ,HELICOBACTER pylori ,PEPTIC ulcer ,STOMACH cancer ,CARCINOGENESIS ,MEDICAL research - Abstract
Background:Helicobacter pylori (H. pylori) was discovered 40 years ago and has set a milestone in human medicine. The discovery led to rejection of the dogma of the acidic stomach as a sterile organ and requested to rewrite the chapters on gastric pathophysiology and gastroduodenal diseases. Summary: Over a period of 40 years following the discovery, more than 50,000 articles can be retrieved in PubMed as of today and illustrate the amount and the intensity of research around the role of this bacterium. H. pylori emerged as cause of chronic gastritis and principal cause of peptic ulcer disease (PUD). Eradication of H. pylori became standard of care in management in PUD. The importance of this was highlighted in 2005 with the Nobel Prize in Medicine awarded to Barry Marshall and Robin Warren. H. pylori became eventually recognized for its oncogenic potential in the stomach and as the main risk factor for gastric cancer development. Key Messages:H. pylori gastritis is defined as infectious disease and requires therapy in all infected individuals. Strategies of gastric cancer prevention and development of therapies to overcome the increasing antibiotic resistance are main targets in clinical research of today. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Molecular mechanisms of antibiotic resistance and novel treatment strategies for helicobacter pylori infections
- Author
-
Srisuphanunt, Mayuna, Wilairatana, Polrat, Kooltheat, Nateelak, Duangchan, Thitinat, Katzenmeier, Gerd, and Rose, Joan B
- Published
- 2023
45. The current infection with Helicobacter pylori and association with upper gastrointestinal lesions and risk of upper gastrointestinal cancer: Insights from multicenter population‐based cohort study.
- Author
-
Yan, Xinxin, Zeng, Hongmei, Li, He, Cao, Maomao, Yang, Fan, He, Siyi, Zhang, Shaoli, Teng, Yi, Li, Qianru, Xia, Changfa, and Chen, Wanqing
- Subjects
GASTROINTESTINAL cancer ,ESOPHAGEAL cancer ,HELICOBACTER pylori infections ,STOMACH cancer ,HELICOBACTER pylori - Abstract
The relationship between Helicobacter pylori (H. pylori) infection and upper gastrointestinal (UGI) cancers is complex. This multicenter, population‐based cohort study conducted in seven areas in China aimed to assess the correlation between current H. pylori infection and the severity of UGI lesions, as well as its association with the risk of gastric cancer (GC) and esophageal cancer (EC). From 2015 to 2017, 27,085 participants (aged 40–69) completed a standardized questionnaire, and underwent a 13C‐urea breath test. Then a subset underwent UGI endoscopy to assess the UGI lesion detection rates. All individuals were followed up until December 2021 to calculate the hazard ratios (HRs) for UGI cancers. H. pylori infection prevalence was 45.9%, and among endoscopy participants, 22.2% had gastric lesions, 19.2% had esophageal lesions. Higher detection rates of gastric lesions were noted in the H. pylori‐positive population across all lesion severity levels. Over a median follow‐up of 6.3 years, 104 EC and 179 GC cases were observed, including 103 non‐cardia gastric cancer (NCGC) cases and 76 cardia gastric cancer (CGC) cases. H. pylori‐infected individuals exhibited a 1.78‐fold increased risk of GC (HR 1.78, 95% confidence interval [CI] 1.32–2.40) but no significant increase in EC risk (HR 1.07, 95% CI 0.73–1.57). Notably, there was a higher risk for both NCGC and CGC in H. pylori‐infected individuals. This population‐based cohort study provides valuable evidence supporting the association between current H. pylori infection and the risk of both NCGC and CGC. These findings contribute to the empirical basis for risk stratification and recommendations for UGI cancer screening. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Real-world evidence of a novel tetravalent immunoglobulin Y effectiveness and safety in patients with the refractory Helicobacter pylori infection.
- Author
-
Hao, Nan, Liu, Bo, Zhao, Meng, Lu, Mingming, Chen, Feiyi, Kang, Jialu, Tang, Xiaojun, Zhang, Yong, and Dang, Chengxue
- Subjects
- *
HELICOBACTER pylori infections , *PATIENT safety , *HELICOBACTER pylori , *WESTERN immunoblotting , *REFRACTORY materials , *BREATH tests - Abstract
Background: Refractory Helicobacter pylori (H. pylori) infection inevitably increase the difficulty of drug selection. Here, we described our experience with the use of a novel tetravalent IgY against H. pylori for the treatment of patients with refractory H. pylori infection. Methods: Patients were randomly assigned to receive the standard quadruple therapy (amoxicillin, clarithromycin, omeprazole and bismuth potassium citrate) for 2 weeks or 250 mg of avian polyclonal IgY orally twice a day for 4 weeks. The binding efficacy of IgY to H. pylori antigens was detected by western blotting13. C-urea breath test was performed to evaluate the eradication therap's efficacy. The side effects of IgY were evaluated via various routine tests. The questionnaire was used to gather clinical symptoms and adverse reactions. Results: Western blot analysis showed that tetravalent IgY simultaneously bind to VacA, HpaA, CagA and UreB of H. pylori. Tetravalent IgY had an eradication rate of 50.74% in patients with refractory H. pylori and an inhibition rate of 50.04% against DOB (delta over baseline) of 13C-urea. The symptom relief rate was 61.76% in thirty-four patients with clinical symptoms, and no adverse reactions were observed during tetravalent IgY treatment period. Conclusions: Polyclonal avian tetravalent IgY reduced H. pylori infection, and showed good efficacy and safety in the treatment of refractory H. pylori infection patients, which represented an effective therapeutic option of choice for patients with refractory H. pylori infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Helicobacter Pylori infection in children with inflammatory bowel disease: a prospective multicenter study.
- Author
-
Dilaghi, Emanuele, Felici, Enrico, Lahner, Edith, Pilozzi, Emanuela, Furio, Silvia, Lucchini, Livia, Quatrale, Giovanna, Piccirillo, Marisa, Parisi, Pasquale, Curto, Sara, Annibale, Bruno, Ferretti, Alessandro, Mennini, Maurizio, Persechino, Severino, and Di Nardo, Giovanni
- Subjects
INFLAMMATORY bowel diseases ,HELICOBACTER pylori infections ,ULCERATIVE colitis ,LONGITUDINAL method - Abstract
Background: The relationship between Helicobacter-pylori(Hp)infection and inflammatory-bowel-disease(IBD) in pediatric-patients remains controversial. We aimed to assess the Hp-infection occurrence in newly-diagnosed pediatric-patients with IBD compared to no-IBD patients. Additionally, we aimed to examine differences in clinical-activity-index(CAI) and endoscopic-severity-score(ESS)between IBD-patients with and without Hp-infection, at baseline and at 1-year-follow-up(FU), after eradication-therapy(ET). Methods: IBD diagnosis was based on Porto-criteria, and all patients underwent gastroscopy at baseline and 1-year FU. For Crohn's-disease(CD) and ulcerative colitis(UC), IBD-CAI and -ESS were classified using PCDAI/SES-CD and PUCAI/UCEIS, respectively. Results: 76 IBD-patients were included in the study[35 F(46.1%),median-age 12(range 2–17)]. CD and UC were diagnosed in 29(38.2%) and 45(59.2%)patients, respectively, and unclassified-IBD in two(2.6%)patients. Non-IBD patients were 148[71 F(48.0%),median-age 12(range 1–17)]. Hp-infection at baseline was reported in 7(9.2%) and 18(12.2%)IBD and non-IBD patients, respectively(p = 0.5065). The 7 IBD patients with Hp infection were compared to 69 IBD patients without Hp-infection at baseline evaluation, and no significant differences were reported considering CAI and ESS in these two groups. At 1-year FU, after ET, IBD patients with Hp infection improved, both for CAI and ESS, but statistical significance was not reached. Conclusion: The occurrence of Hp-infection did not differ between IBD and no-IBD patients. No differences in CAI or ESS were observed at the diagnosis, and after ET no worsening of CAI or ESS was noted at one-year FU, between Hp-positive and -negative IBD patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. The causal relationship between anti-diabetic drugs and gastrointestinal disorders: a drug-targeted mendelian randomization study.
- Author
-
Ju, Mingyan, Deng, Tingting, Jia, Xuemin, Gong, Menglin, Li, Yuying, Liu, Fanjie, and Yin, Ying
- Subjects
- *
GASTROINTESTINAL agents , *METFORMIN , *GASTROINTESTINAL diseases , *CROHN'S disease , *HELICOBACTER pylori infections , *SODIUM-glucose cotransporter 2 inhibitors - Abstract
Background: The incidence of diabetic gastrointestinal diseases is increasing year by year. This study aimed to investigate the causal relationship between antidiabetic medications and gastrointestinal disorders, with the goal of reducing the incidence of diabetes-related gastrointestinal diseases and exploring the potential repurposing of antidiabetic drugs. Methods: We employed a two-sample Mendelian randomization (TSMR) design to investigate the causal association between antidiabetic medications and gastrointestinal disorders, including gastroesophageal reflux disease (GERD), gastric ulcer (GU), chronic gastritis, acute gastritis, Helicobacter pylori infection, gastric cancer (GC), functional dyspepsia (FD), irritable bowel syndrome (IBS), ulcerative colitis (UC), Crohn's disease (CD), diverticulosis, and colorectal cancer (CRC). To identify potential inhibitors of antidiabetic drug targets, we collected single-nucleotide polymorphisms (SNPs) associated with metformin, GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, insulin, and its analogs, thiazolidinediones, sulfonylureas, and alpha-glucosidase inhibitors from published genome-wide association study statistics. We then conducted a drug-target Mendelian randomization (MR) analysis using inverse variance weighting (IVW) as the primary analytical method to assess the impact of these inhibitors on gastrointestinal disorders. Additionally, diabetes was selected as a positive control. Results: Sulfonylureas were found to significantly reduce the risk of CD (IVW: OR [95% CI] = 0.986 [0.978, 0.995], p = 1.99 × 10− 3), GERD (IVW: OR [95% CI] = 0.649 [0.452, 0.932], p = 1.90 × 10− 2), and chronic gastritis (IVW: OR [95% CI] = 0.991 [0.982, 0.999], p = 4.50 × 10− 2). However, they were associated with an increased risk of GU development (IVW: OR [95%CI] = 2 0.761 [1.259, 6.057], p = 1 0.12 × 10− 2). Conclusions: The results indicated that sulfonylureas had a positive effect on the prevention of CD, GERD, and chronic gastritis but a negative effect on the development of gastric ulcers. However, our research found no causal evidence for the impact of metformin, GLP-1 agonists, SGLT2 inhibitors, DPP 4 inhibitors, insulin and its analogs, thiazolidinediones, or alpha-glucosidase inhibitors on gastrointestinal diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Physician perspectives of Helicobacter pylori diagnostic and treatment practices in Canada: results of a Canadian survey.
- Author
-
Cadogan, Kianna, Shaffer, Seth R., Singer, Alexander, Reimer, Aleisha, Knox, Natalie, Rumore, Jillian, Christianson, Sara, Alexander, David C., Forbes, Jessica D., and Bernstein, Charles N.
- Subjects
- *
HELICOBACTER pylori infections , *PHYSICIANS' attitudes , *GASTROENTEROLOGISTS , *HELICOBACTER pylori , *DRUG resistance in bacteria , *PEPTIC ulcer , *PHYSICIANS - Abstract
Background: Helicobacter pylori infection is prevalent worldwide and can lead to peptic ulcer disease (PUD) and gastric cancer. Effective diagnosis and treatment of H. pylori infection by gastroenterologists and family physicians is crucial. However, there are differing views on optimal diagnosis and treatment. The objective of this study is to understand the impressions of Canadian physicians regarding H. pylori diagnosis and treatment and whether impressions differ between gastroenterologists and family physicians. A second objective is to understand physician perspectives on rising antibiotic resistance and how that guides empiric management. Methods: A survey facilitated via REDCap was administered to Canadian gastroenterologists and family physicians. A total of 105 participants completed the survey, including 43 gastroenterologists and 62 family physicians. Gastroenterologists were recruited from across the country and family physicians were recruited from Manitoba. Results: For diagnosis of H. pylori, 67% of gastroenterologists reported endoscopic biopsies for histology assessment as most common and 73% of family physicians reported serology as their main diagnostic test. While nearly all gastroenterologists believed antibiotic resistance to be a problem, nearly one quarter of family physicians did not believe it was a problem. Conclusions: There is variability in practices among both gastroenterologists and family physicians regarding diagnosis of H. pylori infection. There was consensus that local antibiotic resistance patterns should guide management. If known, the degree and patterns of antibiotic resistance could bring a more uniform consensus to H. pylori management. Greater education of physicians, especially family physicians regarding management of H pylori is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Causal link between hypothyroidism and gastric cancer risk: insights gained through multivariable Mendelian randomization and mediation analysis.
- Author
-
Tianyue Zhang, Jie Qiao, Yuanyou Wang, Yinying Zhou, Abdl Sattar Hamoudi, Hammza Jabbar, Al Hendi, Mhd Alaa, and Jun Wang
- Subjects
DISEASE risk factors ,STOMACH cancer ,HYPOTHYROIDISM ,CHRONIC hepatitis B ,GENOME-wide association studies ,HELICOBACTER pylori infections - Abstract
Background: Gastric cancer (GC) is the third leading cause of cancer death worldwide, and hypothyroidism has been identified as a potential influencing factor. Despite known associations between hypothyroidism and various cancers, the causal link between hypothyroidism and GC and potential mediators of this relationship remains unclear. This study aimed to clarify these relationships using Mendelian randomization (MR). Methods: Utilizing genetic variant information from the FinnGen and MRC Integrative Epidemiology Unit open genome-wide association studies (GWAS) databases, we conducted univariable and multivariable MR analyses to explore the causal relationship between hypothyroidism and GC risk. The analysis was adjusted for confounders such as BMI, smoking status, and alcohol intake, and included mediator MR analysis to examine the role of high cholesterol. Results: We identified a significant inverse association between hypothyroidism and GC risk (OR = 0.93, 95% CI= 0.89-0.98, P = 0.003), with no evidence of reverse causation or pleiotropy. Adjustments for Helicobacter pylori infection weakened this association. Mediator analysis highlighted high cholesterol levels, chronic hepatitis B infection, and diabetes/endocrine disease status as significant mediators of the protective effect of hypothyroidism on GC risk. Conclusion: Our findings suggest that hypothyroidism may confer a protective effect against GC, mediated in part by high cholesterol and other factors. These results underscore the importance of thyroid function and metabolic health in GC risk, offering new insights for preventive strategies and highlighting the need for further research into these complex associations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.